Astrana Health (ASTH) vs Onterris (ONT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Astrana Health (ASTH) has outperformed Onterris (ONT) over the past year, gaining 28.4% versus a loss of 13.9%. Over five years, ASTH leads with a -69.4% price change compared with -69.8% for ONT. Astrana Health is the larger company by market cap ($1.44 billion vs $762.4 million), about 1.9 times the size.
On valuation, Astrana Health trades at a lower forward P/E (8.3x vs 12.1x for Onterris). Astrana Health converts more of its revenue into profit, with a net margin of 0.7% versus -0.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ASTH | ONT |
|---|---|---|
| Share price | $28.90 | $21.69 |
| Market cap | $1.44B | $762.40M |
| 1-day change | +0.77% | -7.11% |
| YTD return | +16.49% | -12.65% |
| 1-year return | +28.44% | -13.89% |
| 5-year return | -69.44% | -69.84% |
| P/E ratio (TTM) | 26.76 | — |
| Forward P/E | 8.30 | 12.08 |
| EPS (TTM) | $1.08 | $-0.30 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $3.18B | $830.54M |
| Revenue growth (YoY) | +56.39% | +19.26% |
| Net income (latest FY) | $22.49M | $-843.00K |
| Gross margin | 10.73% | 40.26% |
| Operating margin | 2.47% | 1.41% |
| Net margin | 0.71% | -0.10% |
| 52-week high | $51.60 | $30.00 |
| 52-week low | $18.08 | $12.26 |
| Distance from 52-week high | -43.99% | -27.70% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +79.55% | -3.18% |
| Average volume | 377.18K | 640.62K |
| Shares outstanding | 49.67M | 35.15M |
| Employees | 3,000 | 3,500 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Professional Services | Professional Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ASTH has outperformed ONT by 42.3 percentage points over the past year.
- Astrana Health grew revenue faster in its latest fiscal year (+56.39% vs +19.26%).
About Astrana Health
ASTH stock →Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement.
Consumer Discretionary · Professional Services · 3,000 employees
About Onterris
ONT stock →Onterris, Inc. operates as an environmental services company in the United States, Australia, Canada, and internationally.
Consumer Discretionary · Professional Services · 3,500 employees
ASTH vs ONT FAQ
Which is bigger, Astrana Health or Onterris?
Astrana Health (ASTH) is larger, with a market capitalization of $1.44B compared with $762.40M for Onterris (ONT).
Which stock has performed better over the past year, ASTH or ONT?
ASTH returned +28.44% over the past 12 months, compared with -13.89% for ONT (price return, excluding dividends). Past performance does not predict future results.
Are Astrana Health and Onterris in the same industry?
Yes. Both are classified in the Professional Services industry within the Consumer Discretionary sector.